Topics

New Analyses Allow Restart Of Ipsen's Palovarotene Clinical Program

05:18 EDT 26 Mar 2020 | SCRIP

Ipsen is to restart a global Phase III study of palovarotene in an ultra-rare bone disorder after additional analyses of...

      

Related Stories

 

Original Article: New Analyses Allow Restart Of Ipsen's Palovarotene Clinical Program

NEXT ARTICLE

More From BioPortfolio on "New Analyses Allow Restart Of Ipsen's Palovarotene Clinical Program"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...